HBIO - Harvard Bioscience, Inc.

NasdaqGM - NasdaqGM Delayed Price. Currency in USD
4.70
+0.15 (+3.30%)
At close: 4:00PM EST
Stock chart is not supported by your current browser
Previous Close4.55
Open4.60
Bid3.70 x 100
Ask5.40 x 100
Day's Range4.50 - 4.75
52 Week Range2.25 - 4.85
Volume116,847
Avg. Volume121,998
Market Cap163.938M
Beta1.16
PE Ratio (TTM)N/A
EPS (TTM)-0.09
Earnings DateMar 7, 2018 - Mar 12, 2018
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est7.83
Trade prices are not sourced from all markets
  • GlobeNewswire20 days ago

    Harvard Bioscience Completes Acquisition of Data Sciences International

    HOLLISTON, Mass., Jan. 31, 2018-- Harvard Bioscience, Inc., a global developer, manufacturer and marketer of a broad range of solutions to advance life science, announced today that the Company has completed ...

  • American City Business Journals28 days ago

    Harvard Bioscience snaps up lab equipment firm for $70M

    Harvard Bioscience, a Holliston company that makes life sciences equipment, has agreed to acquire a Minnesota-based firm that makes implantable devices for monitoring blood glucose levels in lab animals. Under the deal, which was announced on Monday and is expected to close by early next month, Harvard Bioscience (HBIO) said it would pay $70 million to buy Data Sciences International. The privately held, 180-employee company makes so-called “telemetry” systems that allow researchers to measure the glucose levels of mice and rats in real time.

  • American City Business Journals28 days ago

    Twin Cities lab animal monitoring company to be sold for $70M

    Data Sciences International, which makes equipment for monitoring lab animals, has reached a deal to be sold to a Massachusetts company for about $70 million. The buyer is Harvard Bioscience, a Holliston, Mass.-based company that makes life sciences equipment. St. Paul-based Data Sciences International has about 180 employees and generated roughly $44 million in revenue last year.

  • GlobeNewswire29 days ago

    Harvard Bioscience To Acquire Data Sciences International and Sells Denville Scientific

    -Conference Call and Webcast Scheduled for Tuesday, January 23 at 7:30 AM ET-. HOLLISTON, Mass., Jan. 22, 2018-- Harvard Bioscience, Inc., a global developer, manufacturer and marketer of a broad range ...

  • Thomson Reuters StreetEvents4 months ago

    Edited Transcript of HBIO earnings conference call or presentation 26-Oct-17 8:30pm GMT

    Q3 2017 Harvard Bioscience Inc Earnings Call

  • Associated Press4 months ago

    Harvard Bioscience reports 3Q loss

    On a per-share basis, the Holliston, Massachusetts-based company said it had a loss of 1 cent. Earnings, adjusted for stock option expense and amortization costs, came to 3 cents per share. The medical ...

  • Harvard Bioscience, Inc. :HBIO-US: Earnings Analysis: Q2, 2017 By the Numbers : October 6, 2017
    Capital Cube5 months ago

    Harvard Bioscience, Inc. :HBIO-US: Earnings Analysis: Q2, 2017 By the Numbers : October 6, 2017

    Categories: Yahoo FinanceGet free summary analysis Harvard Bioscience, Inc. reports financial results for the quarter ended June 30, 2017. We analyze the earnings along side the following peers of Harvard Bioscience, Inc. – Agilent Technologies, Inc. (A-US) that have also reported for this period. Highlights Summary numbers: Revenues of USD 25.21 million, Net Earnings of USD -0.38 ... Read more (Read more...)

  • Thomson Reuters StreetEvents6 months ago

    Edited Transcript of HBIO earnings conference call or presentation 27-Jul-17 8:30pm GMT

    Q2 2017 Harvard Bioscience Inc Earnings Call

  • Associated Press7 months ago

    Harvard Bioscience reports 2Q loss

    The Holliston, Massachusetts-based company said it had a loss of 1 cent per share. Earnings, adjusted for stock option expense and amortization costs, were 3 cents per share. The medical instruments maker ...

  • Capital Cube8 months ago

    ETFs with exposure to Harvard Bioscience, Inc. : July 5, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Harvard Bioscience, Inc. Here are 5 ETFs with the largest exposure to HBIO-US. Comparing the performance and risk of Harvard Bioscience, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)

  • Capital Cube8 months ago

    ETFs with exposure to Harvard Bioscience, Inc. : June 8, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Harvard Bioscience, Inc. Here are 5 ETFs with the largest exposure to HBIO-US. Comparing the performance and risk of Harvard Bioscience, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)

  • Harvard Bioscience, Inc. :HBIO-US: Earnings Analysis: Q1, 2017 By the Numbers : May 10, 2017
    Capital Cube9 months ago

    Harvard Bioscience, Inc. :HBIO-US: Earnings Analysis: Q1, 2017 By the Numbers : May 10, 2017

    Categories: Yahoo FinanceGet free summary analysis Harvard Bioscience, Inc. reports financial results for the quarter ended March 31, 2017. We analyze the earnings along side the following peers of Harvard Bioscience, Inc. – PerkinElmer, Inc., Bruker Corporation, Thermo Fisher Scientific Inc., Johnson & Johnson, Becton, Dickinson and Company, Danaher Corporation, General Electric Company and Bio-Rad Laboratories, Inc. ... Read more (Read more...)

  • Thomson Reuters StreetEvents10 months ago

    Edited Transcript of HBIO earnings conference call or presentation 27-Apr-17 8:30pm GMT

    Q1 2017 Harvard Bioscience Inc Earnings Call

  • Associated Press10 months ago

    Harvard Bioscience reports 1Q loss

    On a per-share basis, the Holliston, Massachusetts-based company said it had a loss of 3 cents. Earnings, adjusted for stock option expense and amortization costs, were 2 cents per share. The medical instruments ...